CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Long Term Provisions | ₹2.72 Cr | ₹2.53 Cr | ₹2.46 Cr | ₹2.08 Cr |
What is the latest Long Term Provisions ratio of CONCORD DRUGS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.72 Cr |
| Mar2024 | ₹2.53 Cr |
| Mar2023 | ₹2.46 Cr |
| Mar2022 | ₹2.08 Cr |
How is Long Term Provisions of CONCORD DRUGS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.72 Cr | 7.51 | |
| Mar2024 | ₹2.53 Cr | 2.64 | |
| Mar2023 | ₹2.46 Cr | 18.23 | |
| Mar2022 | ₹2.08 Cr | - | |
Compare Long Term Provisions of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹99.9 Cr | -3.4% | -7.6% | 12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -3.4% |
-7.6% |
12.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses